{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:05:42Z","timestamp":1774019142512,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s13277-015-3516-x","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T10:13:19Z","timestamp":1430820799000},"page":"7817-7830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender"],"prefix":"10.1007","volume":"36","author":[{"given":"Sarika","family":"Daripally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sateesh Reddy","family":"Nallapalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saritha","family":"Katta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidudala V. T. S.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"key":"3516_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"3516_CR2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3516_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00262-010-0968-0","volume":"60","author":"F Cavallo","year":"2011","unstructured":"Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini PL. 2011: the immune hallmarks of cancer. Cancer Immunol Immunother. 2011;60:319\u201326.","journal-title":"Cancer Immunol Immunother"},{"key":"3516_CR4","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm1296-1306","volume":"2","author":"S Nagata","year":"1996","unstructured":"Nagata S. FAS ligand and immune evasion. Nat Med. 1996;2:1306\u20137.","journal-title":"Nat Med"},{"key":"3516_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMcp071286","volume":"357","author":"M Robson","year":"2007","unstructured":"Robson M, Offit K. Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med. 2007;357:154\u201362.","journal-title":"N Engl J Med"},{"key":"3516_CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3349\/ymj.2009.50.4.464","volume":"50","author":"P Tan","year":"2009","unstructured":"Tan P. Divide and conquer: progress in the molecular stratification of cancer. Yonsei Med J. 2009;50:464\u201373.","journal-title":"Yonsei Med J"},{"key":"3516_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/BJ20101247","volume":"435","author":"J Hageman","year":"2011","unstructured":"Hageman J, van Waarde MA, Zylicz A, Walerych D, Kampinga HH. The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. Biochem J. 2011;435:127\u201342.","journal-title":"Biochem J"},{"key":"3516_CR8","first-page":"307","volume":"16","author":"JH Zhou","year":"2006","unstructured":"Zhou JH, Chen HZ, Ye F, Lu WG, Xie X. FAS-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer. Oncol Rep. 2006;16:307\u201311.","journal-title":"Oncol Rep"},{"key":"3516_CR9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mc.20676","volume":"49","author":"Y Cao","year":"2010","unstructured":"Cao Y, Miao XP, Huang MY, Deng L, Lin DX, Zeng YX, et al. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma. Mol Carcinog. 2010;49:944\u201350.","journal-title":"Mol Carcinog"},{"key":"3516_CR10","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1158\/1078-0432.CCR-05-1739","volume":"12","author":"Z Zhang","year":"2006","unstructured":"Zhang Z, Wang LE, Sturgis EM, El-Naggar AK, Hong WK, Amos CI, et al. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006;12:5596\u2013602.","journal-title":"Clin Cancer Res"},{"key":"3516_CR11","volume":"8","author":"L Xu","year":"2013","unstructured":"Xu L, Zhou X, Jiang F, Qiu MT, Zhang Z, Yin R, et al. FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects. PLoS ONE. 2013;8, e74543.","journal-title":"PLoS ONE"},{"key":"3516_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073700","volume":"8","author":"Z Zhong-Xing","year":"2013","unstructured":"Zhong-Xing Z, Yuan-Yuan M, Hai Zhen M, Jian-Gang Z, Li-Feng Z. FAS -1377G\/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls. PLoS ONE. 2013;8, e73700.","journal-title":"PLoS ONE"},{"key":"3516_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2009.00873.x","volume":"39","author":"LH Wang","year":"2010","unstructured":"Wang LH, Ting SC, Chen CH, Tsai CC, Lung O, Liu TC, et al. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population. J Oral Pathol Med. 2010;39:155\u201361.","journal-title":"J Oral Pathol Med"},{"key":"3516_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07357907.2012.743555","volume":"31","author":"MY Karimi","year":"2013","unstructured":"Karimi MY, Kapoor V, Sharma SC, Das SN. Genetic polymorphisms in FAS (CD95) and FAS ligand (CD178) promoters and risk of tobacco-related oral carcinoma: gene-gene interactions in high-risk Indians. Cancer Investig. 2013;31:1\u20136.","journal-title":"Cancer Investig"},{"key":"3516_CR15","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s13277-014-2896-7","volume":"36","author":"SR Nallapalle","year":"2015","unstructured":"Nallapalle SR, Daripally S, Prasad VVTS. Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently. Tumor Biol. 2015;36:2709\u201324.","journal-title":"Tumor Biol"},{"key":"3516_CR16","unstructured":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed , Accessed 27 Nov 2013."},{"key":"3516_CR17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hed.2880160202","volume":"16","author":"JN Sarkaria","year":"1994","unstructured":"Sarkaria JN, Harari PM. Oral tongue cancer in young adults less than 40\u00a0years of age: rationale for aggressive therapy. Head Neck. 1994;16:107\u201311.","journal-title":"Head Neck"},{"key":"3516_CR18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.oraloncology.2006.10.013","volume":"43","author":"W Garavello","year":"2007","unstructured":"Garavello W, Spreafico R, Gaini RM. Oral tongue cancer in young patients: a matched analysis. Oral Oncol. 2007;43:894\u20137.","journal-title":"Oral Oncol"},{"key":"3516_CR19","author":"JN Weitzel","year":"2011","unstructured":"Weitzel JN, Blazer KR, Mac Donald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine. CA Cancer J Clin. 2011. doi: 10.3322\/caac.20128 .","journal-title":"CA Cancer J Clin"},{"key":"3516_CR20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1128\/MCB.01442-09","volume":"30","author":"D Alfano","year":"2010","unstructured":"Alfano D, Votta G, Schulze A, Downward J, Caputi M, Stoppelli MP, et al. Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor. Mol Cell Biol. 2010;30:1838\u201351.","journal-title":"Mol Cell Biol"},{"key":"3516_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1478-3231.2006.01409.x","volume":"27","author":"I Fabregat","year":"2007","unstructured":"Fabregat I, Roncero C, Fernandez M. Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int. 2007;27:155\u201362.","journal-title":"Liver Int"},{"key":"3516_CR22","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/carcin\/bgs232","volume":"33","author":"D Walerych","year":"2012","unstructured":"Walerych D, Napoli M, Collavin L, Del Sal G. The rebel angel: mutant p53 as the driving oncogene in breast cancer. Carcinogenesis. 2012;33:2007\u201317.","journal-title":"Carcinogenesis"},{"key":"3516_CR23","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.1158\/0008-5472.CAN-10-2720","volume":"70","author":"H Okuyama","year":"2010","unstructured":"Okuyama H, Endo H, Akashika T, Kata K, Inoue M. Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose. Cancer Res. 2010;70:10213\u201323.","journal-title":"Cancer Res"},{"key":"3516_CR24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/ejhg.2009.45","volume":"17","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Qiu L, Wang M, Tong N, Li J, Zhang Z. The FAS ligand promoter polymorphism, rs763110 (\u2212844C\u2009>\u2009T), contributes to cancer susceptibility: evidence from 19 case\u2013control studies. Eur J Hum Genet. 2009;17:1294\u2013303.","journal-title":"Eur J Hum Genet"},{"key":"3516_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2007.09.002","volume":"180","author":"S Kang","year":"2008","unstructured":"Kang S, Dong SM, Seo SS, Kim JW, Park SY. FAS -1377G\/A polymorphism and the risk of lymph node metastasis in cervical cancer. Cancer Genet Cytogenet. 2008;180:1\u20135.","journal-title":"Cancer Genet Cytogenet"},{"key":"3516_CR26","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s13277-013-1339-1","volume":"35","author":"J Zeng","year":"2014","unstructured":"Zeng J, Fang Y, Li P. FAS -1377 A\/G polymorphism in breast cancer: a meta-analysis. Tumour Biol. 2014;35:2575\u201381.","journal-title":"Tumour Biol"},{"key":"3516_CR27","volume":"9","author":"P Geng","year":"2014","unstructured":"Geng P, Li J, Ou J, Xie G, Wang N, Xiang L, et al. Association of FAS -1377G\/A polymorphism with susceptibility to cancer. PLoS ONE. 2014;9, e88748.","journal-title":"PLoS ONE"},{"key":"3516_CR28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2005.05.010","volume":"99","author":"HC Lai","year":"2005","unstructured":"Lai HC, Lin WY, Lin YW, Chang CC, Yu MH, Chen CC, et al. Genetic polymorphisms of FAS and FASL (CD95\/CD95L) genes in cervical carcinogenesis: an analysis of haplotype and gene-gene interaction. Gynecol Oncol. 2005;99:113\u20138.","journal-title":"Gynecol Oncol"},{"key":"3516_CR29","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djh187","volume":"96","author":"T Sun","year":"2004","unstructured":"Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst. 2004;96:1030\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"3516_CR30","first-page":"645","volume":"l40","author":"CJ Watson","year":"2012","unstructured":"Watson CJ, O\u2019Kane H, Maxwell P, Sharaf O, Petak I, Hyland PL, et al. Identification of a methylation hotspot in the death receptor FAS\/CD95 in bladder cancer. Int J Oncol. 2012;l40:645\u201354.","journal-title":"Int J Oncol"},{"key":"3516_CR31","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1182\/blood-2011-09-382770","volume":"119","author":"V Ghanim","year":"2012","unstructured":"Ghanim V, Herrmann H, Heller G, Peter B, Hadzijusufovic E, Blatt K, et al. 5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand. Blood. 2012;119:4242\u201352.","journal-title":"Blood"},{"key":"3516_CR32","first-page":"153","volume":"34","author":"M Yurchenko","year":"2012","unstructured":"Yurchenko M, Shlapatska LM, Sidorenko SP. The multilevel regulation of CD95 signaling outcome. Exp Oncol. 2012;34:153\u20139.","journal-title":"Exp Oncol"},{"key":"3516_CR33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4161\/cc.8.6.7906","volume":"8","author":"I Sancho-Martinez","year":"2009","unstructured":"Sancho-Martinez I, Martin-Villalba A. Tyrosine phosphorylation and CD95: a FAScinating switch. Cell Cycle. 2009;8:838\u201342.","journal-title":"Cell Cycle"},{"key":"3516_CR34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","volume":"30","author":"A Strasser","year":"2009","unstructured":"Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity. 2009;30:180\u201392.","journal-title":"Immunity"},{"key":"3516_CR35","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood-2004-06-2364","volume":"105","author":"N Askenasy","year":"2005","unstructured":"Askenasy N, Yolcu ES, Yaniv I, Shirwan H. Induction of tolerance using FAS ligand: a double-edged immunomodulator. Blood. 2005;105:1396\u2013404.","journal-title":"Blood"},{"key":"3516_CR36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1534\/genetics.106.064964","volume":"175","author":"VJ Clark","year":"2007","unstructured":"Clark VJ, Ptak SE, Tiemann I, Qian Y, Coop G, Di Stone AC, et al. Combining sperm typing and linkage disequilibrium analyses reveals differences in selective pressures or recombination rates across human populations. Genetics. 2007;175:795\u2013804.","journal-title":"Genetics"},{"key":"3516_CR37","first-page":"120","volume":"39","author":"G Kolovou","year":"2009","unstructured":"Kolovou G, Damaskos D, Anagnostopoulou K, Cokkinos DV. Apolipoprotein E gene polymorphism and gender. Ann Clin Lab Sci. 2009;39:120\u201333.","journal-title":"Ann Clin Lab Sci"},{"key":"3516_CR38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4236\/jbise.2014.78049","volume":"7","author":"AL Lorenz","year":"2014","unstructured":"Lorenz AL, Kahre T, Mihailov E, Nikopensius T, Lotman EM, Metspalu A, et al. Are Methylenetetrahydrofolate Reductase (MTHFR) Gene polymorphisms C677T and A1298C associated with higher risk of pediatric migraine in boys and girls? J Biomed Sci Eng. 2014;7:464\u201372.","journal-title":"J Biomed Sci Eng"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3516-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3516-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3516-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:29:21Z","timestamp":1559489361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3516-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3516"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3516-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]}}}